| Analysis | Metabolite Name | Measured Value | Units | Genotype | Treatment |
|---|---|---|---|---|---|
| Reversed phase UNSPECIFIED ION MODE | FA160 | 17120.28135 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 17754.95279 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 20896.25672 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 21607.99031 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 21971.75185 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 22035.73799 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 24797.68506 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 27869.08981 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 29468.06947 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 34800 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 36815.10583 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 42514.70599 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 45946.35334 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 46282.64118 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 47167.95362 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 47295.14831 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 48519.82405 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 52911.73379 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 55749.56466 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 57535.61616 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 58145.2291 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 63942.32825 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 67460.4193 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 70160.02417 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 92315.59795 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 100782.0402 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 106420.1174 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 130781.9726 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 146404.2333 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 174087.0432 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 179075.453 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA160 | 221575.9885 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA160 | intensity | Wild-type | LPS | |
| Reversed phase UNSPECIFIED ION MODE | FA160 | intensity | Wild-type | LPS+antiPla2g5 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|